[Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].
Ramanauskaĭte
R Iu
RIu
Abronina
I F
IF
Karaseva
L I
LI
Sergeev
A V
AV
D000818:Animals; D002338:Carotenoids / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D003208:Concanavalin A; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D007111:Immunity, Cellular / Q000187:drug effects*; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects; D019207:beta Carotene
D019207:beta Carotene; D003208:Concanavalin A; D002338:Carotenoids; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
Korrektsiia beta-karotinom proteivoopukholevogo immuniteta pri éksperimental'noĭ khimioterapii zlokachestvennykh novoobrazovaniĭ.